Documents
201 documents
Sort by:
Subscribe to the latest documents
- Date
- Relevance
-
Declaration Member State of origin parallel import
-
Declaration for information intended for healthcare professionals of parallel imported products
-
Application for parallel import marketing authorisation
-
EMA: form for reporting a suspected adverse event of a veterinary medicinal product
-
Braille declaration
-
MEB Regulatory Science Day 2017
-
Classification overview legal status of supply NSAIDs
The MEB has determined a classification system for OTC anti-inflammatories (NSAIDs).
-
Assessment report DHA-rich algal oil, applicant NovoSana (Europe) B.V.
A report on the assessment of DHA-rich algal oil by the company NovoSana (Europe) B.V. for substantial equivalence to DHA-rich ...
-
Assessment report Chia seed, applicant DFInternational BV
A report on the assessment of chia seed by the company DFInternational B.V. for substantial equivalence to chia seed, which has ...
-
MEB 41: MEB policy concerning marketing authorisations without Dutch translations of the product information and/or mock-ups
The MEB is aware of the fact that medicinal products are not always marketed immediately after authorisation. Following the ...